דני שלי מהנדסים

29/03/2024

שבת שלום ושקט חברים מנארה פארק יפן.

07/02/2024

23/07/2023

Last week members of the management team of Orgenesis Biotech Israel Ltd. (Orgenesis) a product development firm and subsidiary of Orgenesis Inc., that is developing a drug therapy for Myasthenia Gravis, a neuroimmunological disease causing weakness and muscle fatigue, visited the neuroimmunological laboratory at the Technion-Israel Institute of Technology under the directorship of Dr. Shahar Shelly, head of the Neuromascular Clinic in the Department of Neurology at Rambam Health Care Campus (Rambam) in Haifa, Israel.
Following the successful launch of the new FDA approved medicine a few months ago, the visitors from Orgenesis met with Dr. Shelly, a global leader in the field of Myasthenia Gravis, to discuss research findings in the treatment of the illness and to discuss cooperation with Medison Pharma, an Israeli pharma company.

09/04/2023

בשעה טובה מפרקים את העגורן באשדוד

23/11/2022

לב הרובע אשדוד